Allyson Price, MPAS, PA-C, on Predicting Drug Response in Acute Lymphoblastic Leukemia

Allyson Price, MPAS, PA-C, of The University of Texas MD Anderson Cancer Center, discusses gene drug mapping, the future of precision medicine in leukemia, and the need for advanced practitioners to educate this patient population who may be new to the use of oral medications.